Ertapenem Sodium Patent Expiration
Ertapenem Sodium is Used for treating bacterial infectious diseases. It was first introduced by Merck Sharp And Dohme Llc A Sub Of Merck And Co Inc
Ertapenem Sodium Patents
Given below is the list of patents protecting Ertapenem Sodium, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Invanz | US5478820 | Antibiotic compounds |
Nov 21, 2015
(Expired) | Msd Sub Merck |
| Invanz |
US5478820 (Pediatric) | Antibiotic compounds |
May 21, 2016
(Expired) | Msd Sub Merck |
| Invanz | US5652233 | Antibiotic compounds |
Feb 02, 2013
(Expired) | Msd Sub Merck |
| Invanz |
US5652233 (Pediatric) | Antibiotic compounds |
Aug 02, 2013
(Expired) | Msd Sub Merck |
| Invanz | US5952323 | Carbapenem antibiotic |
May 15, 2017
(Expired) | Msd Sub Merck |
| Invanz |
US5952323 (Pediatric) | Carbapenem antibiotic |
Nov 15, 2017
(Expired) | Msd Sub Merck |
| Invanz | US7342005 | Antibiotic compounds |
Feb 02, 2013
(Expired) | Msd Sub Merck |
| Invanz |
US7342005 (Pediatric) | Antibiotic compounds |
Aug 02, 2013
(Expired) | Msd Sub Merck |
Coming Soon
Patent Strength Analyzer
YesNo
Thank you for your response 🥳
Ertapenem Sodium Generics
Several generic applications have been filed for Ertapenem Sodium. The first generic version for Ertapenem Sodium was by Acs Dobfar Spa and was approved on Apr 16, 2018. And the latest generic version is by Sun Pharmaceutical Industries Ltd and was approved on May 2, 2023.
Given below is the list of companies who have filed for Ertapenem Sodium generic.
1. ACS DOBFAR SPA
Acs Dobfar Spa has filed for 1 generic for Ertapenem Sodium. Given below are the details of the strengths of this generic introduced by Acs Dobfar Spa.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 1GM BASE/VIAL | injectable | Prescription | INTRAMUSCULAR, INTRAVENOUS | AP | Apr 16, 2018 |
2. GLAND PHARMA LTD
Gland Pharma Ltd has filed for 1 generic for Ertapenem Sodium. Given below are the details of the strengths of this generic introduced by Gland Pharma Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 1GM BASE/VIAL | injectable | Prescription | INTRAMUSCULAR, INTRAVENOUS | AP | Mar 26, 2021 |
3. SUN PHARM
Sun Pharmaceutical Industries Ltd has filed for 1 generic for Ertapenem Sodium. Given below are the details of the strengths of this generic introduced by Sun Pharm.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 1GM BASE/VIAL | injectable | Discontinued | INTRAMUSCULAR, INTRAVENOUS | N/A | May 2, 2023 |
4. EUGIA PHARMA
Eugia Pharma Specialities Ltd has filed for 1 generic for Ertapenem Sodium. Given below are the details of the strengths of this generic introduced by Eugia Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 1GM BASE/VIAL | injectable | Prescription | INTRAMUSCULAR, INTRAVENOUS | AP | Jun 25, 2018 |
5. SAVIOR LIFETEC CORP
Savior Lifetec Corp has filed for 1 generic for Ertapenem Sodium. Given below are the details of the strengths of this generic introduced by Savior Lifetec Corp.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 1GM BASE/VIAL | injectable | Prescription | INTRAMUSCULAR, INTRAVENOUS | AP | Mar 19, 2019 |